Global Chief Medical Officer

Legend Biotech
Somerset, New Jersey, United StatesPosted 23 February 2026

Job Description

<div class="content-intro"><p style="line-height: 1.2;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three RD sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.</span></p> <p style="line-height: 1.2;"> </p> <p style="line-height: 1.2;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.</span></p> <p style="line-height: 1.2;"> </p></div><div class="col-xs-12 no-horiz-padding"><hr> <p><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;">Legend Biotech is seeking a <strong>Global Chief Medical Officer </strong>as part of the <strong>Clinical Development </strong>team based in <strong>Somerset, NJ.</strong></span></p> <p> </p> <p><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong>Role Overview</strong></span></p> <p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech is a global, integrated cell therapy company dedicated to discovering, developing, and manufacturing transformative therapies for patients with cancer, autoimmune, and other serious diseases. The company has a vision of harnessing the power of the immune system to create durable and potentially curative treatments. By combining deep scientific expertise with advanced manufacturing and global execution capabilities, Legend Biotech aims to change the way the world treats disease and to make cutting-edge cell therapies broadly accessible to patients.</span></p> <p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech is at the forefront of cell therapy research and development. In pursuit of cure, the company is leveraging its integrated autologous, allogeneic and in vivo cell therapy platforms to design and deliver therapies that can reprogram immune cells to precisely target and eliminate the root cause of diseases, including cancers and autoimmune diseases.</span></p> <p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Legend Biotech is recruiting an accomplished drug developer and a visionary organization/business leader as Global Chief Medical Officer (CMO) who will serve as the senior clinical development leader for our ongoing clinical programs and teams in both the United States and China. This role is pivotal in overseeing the global clinical development strategy, ensuring the safety, efficacy, and regulatory compliance of the company’s innovative therapies, and shaping the clinical vision for the company’s pipeline.</span></p> <p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Reporting to President of Research and Development, the Global CMO will work closely with the executive leadership team, regulatory authorities, and key external stakeholders to lead the clinical development program from pre-clinical stages through to post-market activities. Additionally, the Global CMO will act as a strategic thought leader in the field of cell and gene therapy and provide clinical expertise in the design, execution, and interpretation of clinical trials, regulatory subm ... (truncated, view full listing at source)